In contrast to the results from previous studies,29, 30 we did not observe PFS to be a surrogate endpoint for OS in our patients with EGFR‐mutated NSCLC administered first‐line EGFR‐TKI, although PPS was not evaluated in the previous reports. Here, EGFR is linked to non-small cell lung carcinoma.